Annovex Pharma, Inc.
FDA inspection history in Lorton, Virginia, 2024 to 2026
- 2
- Form 483s
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2024: one Form 483; 2025: one warning letter; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024–26Two Form 483s and one warning letter, at Lorton, Virginia.
- 2024The longest 483 on file: 7 observations over 5 pages at Lorton, Virginia.
Cited most
Across all Annovex Pharma observations on file
- 21 CFR 211.180General requirements2
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Annovex Pharma file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Lorton, Virginia
Two Form 483s and one warning letter · 2024 to 2026 · 9 observations
Latest: Form 483, May 27, 2026 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-05-27 | 483 Form 483 | Lorton, Virginia | 2 | $99 |
| 2025-03-05 | Warning letter Warning letter | Lorton, Virginia | — | $99 |
| 2024-09-06 | 483 Form 483 | Lorton, Virginia | 7 | $99 |
Investigators on these documents
Christina K. Theodorou (1)Kara J. Wright (1)Tekalign Wondimu (1)Yaharn Su (1)
FEI number 3020928491 · most recent document May 27, 2026
About Annovex Pharma, Inc.
How many FDA Form 483s has Annovex Pharma, Inc. received?
FDA Intel has 2 Form 483s on file for Annovex Pharma, Inc.; the most recent is dated May 27, 2026.
When was Annovex Pharma, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Annovex Pharma, Inc. is a Form 483 dated May 27, 2026, for the site in Lorton, Virginia.
What did FDA cite at Annovex Pharma, Inc.?
The regulations cited most in the observations on file for Annovex Pharma, Inc. are 21 CFR 211.180 (General requirements), 2 times; 21 CFR 211.42 (Design and construction features), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time.
Has Annovex Pharma, Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Annovex Pharma, Inc.; the most recent is dated Mar 5, 2025.